Clinical trials: Hair Diseases
Polycystic Ovary Syndrome
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
The aim of this study is to determine the effect of the treatment of polycystic ovary syndrome with two different oral contraceptives that contain cyproterone acetate and drospirenone
- Trial name
- NCT04831151
- Testing
- Yasmin, Diane-35
- Where
- Turkey (Türkiye)
- Volunteers
- 42 people
- Sponsor
- Inonu University
Alopecia, Androgenetic
Role of Vitamin D in Androgenetic Alopecia
Androgenetic alopecia is a common form of diffuse hair loss in both men and women,It primarily affects the top and front of the scalp with different clinical presentations and there are numerous classification systems for grading…
- Trial name
- NCT03154528
- Testing
- serum vitamin D level by ELISA
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Assiut University
Alopecia, Breast Cancer
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
RATIONALE: Bimatoprost ophthalmic solution may help increase eyebrow and eyelash growth in patients who have undergone chemotherapy.
- Trial name
- NCT00999557
- Testing
- bimatoprost ophthalmic solution
- Where
- United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- Jonsson Comprehensive Cancer Center
Post Traumatic Stress Disorder
Hair Cortisol Level as a Predictor of PTSD Development
Post-traumatic stress disorder, PTSD, is one of the most prevalent psychiatric disorders. As casualties of motor vehicle accidents, criminal acts or terrorism are arriving to the ER, it is almost impossible to conclude who will…
- Trial name
- NCT01804426
- Where
- Israel
- Volunteers
- healthy volunteers welcome
- Sponsor
- Shalvata Mental Health Center
Alopecia
Hairstetics Hair Implant Device Safety and Efficacy
This is a prospective, single-arm, multi-center, international, open-label, non-randomized, clinical study. The aim of the study is to assess the safety and efficacy of the use of the Hairstetics hair implant device in subjects…
- Trial name
- NCT02856308
- Testing
- Hairstetics hair implant device
- Where
- 8 sites in France, India and 2 more
- Volunteers
- 100 people
- Sponsor
- Hairstetics
Alopecia Areata
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
Alopecia areata (AA) presents with circumscribed patches of non-scarring hair loss. It inflects a significant psychological and social burden. Many treatment options are used for the treatment of AA.
- Trial name
- NCT03535233
- Testing
- Triamcinolone Acetonide, Minoxidil 5 % Topical Spray, clobetasol propionate
- Volunteers
- 40 people
- Sponsor
- Cairo University
Cancer
A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
The goal of this observational study is to learn about biomarkers in patients with certain types of malignant solid tumours (cancer).
- Trial name
- NCT05574738
- Testing
- Observational
- Where
- United Kingdom
- Volunteers
- 1,000 people
- Sponsor
- Eileen Soulis
Alopecia Areata
Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluation
Alopecia areata is the most frequent cause of inflammation-induced hair loss with prevalence from 0.1 to 0.2%. It has no age nor sex predilection .
- Trial name
- NCT03473600
- Testing
- Cryotherapy, Triamcinolone acetonide injection
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Assiut University
Hair Loss, Hair Thinning
Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss
Hair loss study in men with self-perceived thinning hair and loss
- Trial name
- NCT03709563
- Testing
- Oral Nutraceutical Supplement
- Where
- United States
- Volunteers
- 74 people, healthy volunteers welcome
- Sponsor
- DeNova Research
Breast Cancer, Pregnancy Related
Hair Care Product Use Among Women Of Color
The purpose of this study is to reduce use of personal care products that contain endocrine disrupting chemicals among women. For this pilot intervention, the investigators focus on the hair care product class of personal care…
- Conditions
- Breast Cancer, Pregnancy Related, Exposure During Pregnancy
- Trial name
- NCT04493892
- Testing
- Educational Intervention
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- Columbia University
Female Pattern Hair Loss, Androgenetic Alopecia
Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
5% topical minoxidil is the maximum dosage approved by the US FDA for the treatment of female pattern hair loss. While topical minoxidil exhibits a good safety profile, the efficacy in the overall population is relatively low…
- Trial name
- NCT02486848
- Testing
- 5% Topical Minoxidil Solution, 15% Topical Minoxidil Solution
- Where
- Italy
- Sponsor
- Maja Kovacevic, MD
Alopecia, Chemotherapy-Induced Change
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
Primary aim is to provide a preliminary assessment of the efficacy of the investigational topical formula, KGF-HS, as a prophylactic treatment for chemotherapy induced alopecia.
- Conditions
- Alopecia, Chemotherapy-Induced Change, Hair Loss, Alopecia Drugs
- Trial name
- NCT04554732
- Testing
- Keratinocyte growth factor
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- University of Arizona
Alopecia
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Clinical alopecia occurs due to miniaturization of the hair shafts as well as loss of active production of hair shafts. PRFM has been shown to induce dermal angiogenesis, and anecdotal findings of improvement of hair appearance…
- Trial name
- NCT01590238
- Testing
- PRFM treatment
- Where
- United States
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- The New York Eye & Ear Infirmary
Androgenetic Alopecia
Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia
The primary purpose of this study is to assess the safety of performing injections of human autologous hair follicle cells. The study will also measure the impact these injections will have on hair growth.
- Trial name
- NCT01286649
- Testing
- Human autologous hair follicle cells, Cell medium
- Where
- Georgia
- Volunteers
- 19 people
- Sponsor
- TrichoScience Innovations, Inc.
Female Pattern Baldness
Radiofrequency in Female Pattern Hair Loss
Pattern hair loss, also called androgenetic alopecia (AGA) is considered the most common cause of hair loss in both males and females affecting approximately 85% of males and 50% of females over 50 years of age.
- Trial name
- NCT05409755
- Testing
- Vivacy
- Volunteers
- 30 people
- Sponsor
- Cairo University
Acne Keloidalis Nuchae
The Efficacy of Laser Assisted Hair Removal in the Treatment of Acne Keloidalis Nuchae; a Pilot Study
Laser causes elimination and miniaturization of hair shafts that are the principal contributor to inflammation in Acne Keloidalis Nuchae (AKN).
- Trial name
- NCT01548898
- Testing
- Nd-YAG laser
- Volunteers
- 16 people
- Sponsor
- Cairo University
Breast Neoplasms, Alopecia
Effect of Cryotherapy in the Prevention of Madarosis Produced by Chemotherapy in Breast Cancer Patients
Chemotherapy-induced alopecia (CIA) significantly compromises body image in breast cancer patients, particularly when involving eyebrow and eyelash loss (madarosis).
- Conditions
- Breast Neoplasms, Alopecia, Madarosis, Eyebrow Diseases
- Trial name
- NCT06955702
- Testing
- cryotherapy for chemotherapy-induced madarosis
- Where
- 2 sites in Spain
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- University of Salamanca
Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA)
Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
This study is testing CG2001, a new medicine that is applied as a light foam to the scalp and is being developed to treat male-pattern hair loss (androgenetic alopecia). The main goals are to find out: 1.
- Trial name
- NCT07038941
- Testing
- CG2001
- Where
- China
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Beijing Dayspring Pharmaceutical Technology Co., Ltd
Alopecia, Male Pattern Hair Loss
To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
The study is a randomized, double-blind, placebo-controlled, parallel group, phase 2 study to evaluate the efficacy, safety and tolerability of KX-826 in male subjects with androgenetic alopecia.
- Trial name
- NCT05218642
- Testing
- KX- 826 dosed at 2.5mg, KX-826 dosed at 5mg
- Where
- 10 sites in United States
- Volunteers
- 123 people, healthy volunteers welcome
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
Cushing's Syndrome
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
This is an observational study to confirm the presence of recurrent or persistent endogenous Cushing's syndrome in patients who have had primary surgical and/or radiation therapy for Cushing's disease and continue to manifest…
- Trial name
- NCT00796783
- Testing
- Cushing's syndrome confirmation
- Where
- 3 sites in United States
- Volunteers
- 2 people
- Sponsor
- Corcept Therapeutics